Literature DB >> 16613895

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Keith A Josephs1, Joseph R Duffy, Edyth A Strand, Jennifer L Whitwell, Kenneth F Layton, Joseph E Parisi, Mary F Hauser, Robert J Witte, Bradley F Boeve, David S Knopman, Dennis W Dickson, Clifford R Jack, Ronald C Petersen.   

Abstract

Apraxia of speech (AOS) is a motor speech disorder characterized by slow speaking rate, abnormal prosody and distorted sound substitutions, additions, repetitions and prolongations, sometimes accompanied by groping, and trial and error articulatory movements. Although AOS is frequently subsumed under the heading of aphasia, and indeed most often co-occurs with aphasia, it can be the predominant or even the sole manifestation of a degenerative neurological disease. In this study we determine whether the clinical classifications of aphasia and AOS correlated with pathological diagnoses and specific biochemical and anatomical structural abnormalities. Seventeen cases with initial diagnoses of a degenerative aphasia or AOS were re-classified independently by two speech-language pathologists--blinded to pathological and biochemical findings--into one of five operationally defined categories of aphasia and AOS. Pathological diagnoses in the 17 cases were progressive supranuclear palsy in 6, corticobasal degeneration in 5, frontotemporal lobar degeneration with ubiquitin-only-immunoreactive changes in 5 and Pick's disease in 1. Magnetic resonance imaging analysis using voxel-based morphometry (VBM), and single photon emission tomography were completed, blinded to the clinical diagnoses, and clinicoimaging and clinicopathological associations were then sought. Interjudge clinical classification reliability was 87% (kappa = 0.8) for all evaluations. Eleven cases had evidence of AOS, of which all (100%) had a pathological diagnosis characterized by underlying tau biochemistry, while five of the other six cases without AOS did not have tau biochemistry (P = 0.001). A majority of the 17 cases had more than one yearly evaluation, demonstrating the evolution of the speech and language syndromes, as well as motor signs. VBM revealed the premotor and supplemental motor cortices to be the main cortical regions associated with AOS, while the anterior peri-sylvian region was associated with non-fluent aphasia. Refining the classification of the degenerative aphasias and AOS may be necessary to improve our understanding of the relationships among behavioural, pathological and imaging correlations.

Entities:  

Mesh:

Year:  2006        PMID: 16613895      PMCID: PMC2748312          DOI: 10.1093/brain/awl078

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  64 in total

1.  A new brain region for coordinating speech articulation.

Authors:  N F Dronkers
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

Review 2.  Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia.

Authors:  R S Turner; L C Kenyon; J Q Trojanowski; N Gonatas; M Grossman
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

3.  Patterns of cerebral atrophy in primary progressive aphasia.

Authors:  Howard J Rosen; Joel H Kramer; Maria Luisa Gorno-Tempini; Norbert Schuff; Michael Weiner; Bruce L Miller
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

4.  Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report.

Authors:  Maria Luisa Gorno-Tempini; Ryan C Murray; Katherine P Rankin; Michael W Weiner; Bruce L Miller
Journal:  Neurocase       Date:  2004-12       Impact factor: 0.881

Review 5.  Establishing a pathological diagnosis in degenerative dementias.

Authors:  J Lowe
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

Review 6.  Pick's disease: a modern approach.

Authors:  D W Dickson
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

7.  Slowly progressive aphasia without generalized dementia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

8.  Progressive aphasia in a patient with Pick's disease: a neuropsychological, radiologic, and anatomic study.

Authors:  N R Graff-Radford; A R Damasio; B T Hyman; M N Hart; D Tranel; H Damasio; G W Van Hoesen; K Rezai
Journal:  Neurology       Date:  1990-04       Impact factor: 9.910

9.  Progressive Nonfluent Aphasia: Language, Cognitive, and PET Measures Contrasted with Probable Alzheimer's Disease.

Authors:  M Grossman; J Mickanin; K Onishi; E Hughes; M D'Esposito; X S Ding; A Alavi; M Reivich
Journal:  J Cogn Neurosci       Date:  1996       Impact factor: 3.225

10.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

View more
  256 in total

1.  Statistical parametric mapping demonstrates asymmetric uptake with Tc-99m ECD and Tc-99m HMPAO SPECT in normal brain.

Authors:  Benjamin H Brinkmann; David T Jones; Matt Stead; Noojan Kazemi; Terence J O'Brien; Elson L So; Hal Blumenfeld; Brian P Mullan; Gregory A Worrell
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-21       Impact factor: 6.200

Review 2.  The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants.

Authors:  Michael F Bonner; Sharon Ash; Murray Grossman
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

Review 3.  Biomarkers to identify the pathological basis for frontotemporal lobar degeneration.

Authors:  Murray Grossman
Journal:  J Mol Neurosci       Date:  2011-07-22       Impact factor: 3.444

4.  Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study.

Authors:  E Gordon; J D Rohrer; L G Kim; R Omar; M N Rossor; N C Fox; J D Warren
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

Review 5.  The diagnosis and understanding of apraxia of speech: why including neurodegenerative etiologies may be important.

Authors:  Joseph R Duffy; Keith A Josephs
Journal:  J Speech Lang Hear Res       Date:  2012-10       Impact factor: 2.297

6.  Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.

Authors:  Eoin P Flanagan; Matthew C Baker; Ralph B Perkerson; Joseph R Duffy; Edythe A Strand; Jennifer L Whitwell; Mary M Machulda; Rosa Rademakers; Keith A Josephs
Journal:  Dement Geriatr Cogn Disord       Date:  2015-02-28       Impact factor: 2.959

7.  The neuroanatomy of pure apraxia of speech in stroke.

Authors:  Jonathan Graff-Radford; David T Jones; Edythe A Strand; Alejandro A Rabinstein; Joseph R Duffy; Keith A Josephs
Journal:  Brain Lang       Date:  2014-02-18       Impact factor: 2.381

Review 8.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10

9.  Symmetric corticobasal degeneration (S-CBD).

Authors:  Anhar Hassan; Jennifer L Whitwell; Bradley F Boeve; Clifford R Jack; Joseph E Parisi; Dennis W Dickson; Keith A Josephs
Journal:  Parkinsonism Relat Disord       Date:  2009-12-16       Impact factor: 4.891

Review 10.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.